ESC-HFA 2023: Late-Breaking Science Video Collection

Published: 23 May 2023

  • Views:

    Views Icon 1548
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating


Get the most out of the new data from, Late-breaker host, Dr Harriette Van Spall and Dr James Januzzi wrap up of the most impactful trials and studies presented at Heart Failure 2023.

Delve into in-depth and critical discussions with Dr Van Spall in our thought-provoking Late-breaker Discussion series.

For concise and practical take-home messages for practice and cardiovascular research watch our 5-minute Expert Interviews conducted with investigators.

Watch our Behind the Heart Series to hear more from the personal perspectives of the investigators behind the top trials of HFA 2023. 

More from this programme

About the episode

Prof John Cleland (University of Glasgow, Glasgow, UK) discusses the findings from a study that looked at the diagnostic of heart failure in a cohort of 1.1 million people using the NHS EMR database. 
Finding presented at Heart Failure 2023, showed that more people treated with LD than receive diagnosis of heart failure, this disparity was greater in women compared to men. 

Interview Questions:
1. What is the background of this study?
2. What is the definition of heart failure in 2023?
3. Could you provide details about the study's methodology and the characteristics of the patient cohort?
4. What are the findings? 
5. To what extent can these findings be generalised or applied to patients in different healthcare systems?
6. What are the take home messages for practice?

Faculty Biographies

John GF Cleland

John GF Cleland

Professor of Cardiology

Prof John Cleland is a Professor of Cardiology at University of Glasgow, Glasgow, UK.

In 1977, he qualified from the University of Glasgow, completed training at St. Mary's & Hammersmith Hospitals (London) and was awarded a Senior Fellowship by the British Heart Foundation.

His main interests include heart failure, extending from epidemiology & prevention, to Phase II-IV trials and guidelines. 

He founded the European Journal of Heart Failure and is Past-Chair of the ESC Working Group on heart failure and British Society for Heart Failure.




View full profile


You must be to comment. If you are not registered, you can register here.